Aldrichimica Acta
For more than 50 years, the Aldrichimica Acta has been a leading, open-access, international forum for the frontiers of chemical research. It publishes topical and insightful reviews, written by prominent chemists from around the world and covering a variety of topics usually based on a synthetic theme in organic, organometallic, and bio-organic chemistry.
In our newest issue, Aldrichimica Acta 2022, Vol. 55, No. 1, read about:
- Peptide-Mediated Strategies for Intracellular Protein Delivery.
- Chiral Organosuperbase Catalysts as Useful Tools for Developing Enantioselective Reactions.
- Difunctionalization-Type Fluoroalkylations of Alkenes via Intramolecular Carbo- or Heterocycle Formation.
Cover art: Detail from Cherry Blossom Viewing. The Freer Gallery of Art, Washington, D.C.
Archives
Aldrichimica Acta's 50-plus years are archived by volume in PDF format. You can print and download documents or read them online. Enjoy!
2021 Vol. 54
2020 Vol. 53
2019 Vol. 52
2018 Vol. 51
2017 Vol. 50
2016 Vol. 49
2015 Vol. 48
2014 Vol. 47
2013 Vol. 46
2012 Vol. 45
2011 Vol. 44
2010 Vol. 43
2009 Vol. 42
2008 Vol. 41
2007 Vol. 40
2006 Vol. 39
2005 Vol. 38
2004 Vol. 37
2003 Vol. 36
2002 Vol. 35
2001 Vol. 34
2000 Vol. 33
1999 Vol. 32
1998 Vol. 31
1997 Vol. 30
1996 Vol. 29
1995 Vol. 28
1994 Vol. 27
1993 Vol. 26
1992 Vol. 25
1991 Vol. 24
1990 Vol. 23
1989 Vol. 22
1988 Vol. 21
1987 Vol. 20
1986 Vol. 19
1985 Vol. 18
1984 Vol. 17
1983 Vol. 16
1982 Vol. 15
1981 Vol. 14
1980 Vol. 13
1979 Vol. 12
1978 Vol. 11
1977 Vol. 10
1976 Vol. 9
1975 Vol. 8
1974 Vol. 7
1973 Vol. 6
1972 Vol. 5
1971 Vol. 4
1970 Vol. 3
1969 Vol. 2
1968 Vol. 1
Support
Customer SupportContact UsFAQSafety Data Sheets (SDS)Certificates (COA/COO)Quality & RegulatoryCalculators & AppsWebinarsSocial Media
MilliporeSigma
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.
© 2022 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.
Reproduction of any materials from the site is strictly forbidden without permission.